A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer | MicrobiomeTrials← Back to trialsNCT04190446
A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2020-01-06Est. Completion: 2025-11-22
Enrollment target: 84 participants Locations- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Gastro-Oesophageal Cancer
To determine if the regorafenib and nivolumab combination (RegoNivo) improves overall survival compared with current sta…
Scottsdale, United StatesCompleted Jan 14, 2025
Prostate Cancer (Adenocarcinoma)
This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be low…
Anchorage, United StatesEst. completion Mar 14, 2031
Recruiting
Prostate CancerHepatocellular CarcinomaOvarian CancerSolid TumorsEndometrial CancerFAPIPSMA
This study aims to evaluate a novel dual-targeted PET imaging tracer, 68Ga-FAPI-PSMA, for the detection and evaluation o…
Multiple LocationsEst. completion Dec 31, 2026